Jusko WJ and D'Ambrosio R |
Monitoring FK 506 concentrations in plasma and whole blood. |
1991 |
Transplant. Proc. |
pmid:1721260
|
Venkataramanan R et al. |
Pharmacokinetics of FK 506 in transplant patients. |
1991 |
Transplant. Proc. |
pmid:1721261
|
Akselband Y et al. |
Rapamycin inhibits spontaneous and fibroblast growth factor beta-stimulated proliferation of endothelial cells and fibroblasts. |
1991 |
Transplant. Proc. |
pmid:1721292
|
Schreiber SL et al. |
Immunophilin-ligand complexes as probes of intracellular signaling pathways. |
1991 |
Transplant. Proc. |
pmid:1721293
|
Motta I et al. |
FK 506 favors the generation of memory T cells in vitro. |
1991 |
Transplant. Proc. |
pmid:1721324
|
Nakata S et al. |
Immunosuppressive effect of FK 506 on cytotoxic T lymphocytes and delayed-type hypersensitivity in rats. |
1991 |
Transplant. Proc. |
pmid:1721325
|
Whiteside TL et al. |
Serial monitoring of immunologic function and phenotype of lymphocytes in the blood of transplanted patients randomized to cyclosporine or FK 506. |
1991 |
Transplant. Proc. |
pmid:1721356
|
Frayha HH et al. |
Lymphoproliferative disorder in a liver transplant patient on FK 506. |
1991 |
Lancet |
pmid:1703258
|
Van Thiel DH et al. |
Interferon therapy of hepatitis following liver transplantation under FK 506 or cyclosporine. |
1991 |
Transplant. Proc. |
pmid:1721357
|
Burman K and Crawford DH |
Effect of FK 506 on Epstein-Barr virus specific cytotoxic T cells. |
1991 |
Lancet |
pmid:1703259
|
Winkler M et al. |
Association of elevated FK 506 plasma levels with nephrotoxicity in liver-grafted patients. |
1991 |
Transplant. Proc. |
pmid:1721389
|
Schmidt RJ et al. |
Hemolytic-uremic syndrome in a renal transplant recipient on FK 506 immunosuppression. |
1991 |
Transplant. Proc. |
pmid:1721390
|
Cooper MH et al. |
The induction of pseudo-graft-versus-host disease following syngeneic bone marrow transplantation using FK 506. |
1991 |
Transplant. Proc. |
pmid:1721419
|
Boggs S et al. |
FK 506 has no short-term effects on endogenous or exogenous myeloid reconstitution in irradiated mice. |
1991 |
Transplant. Proc. |
pmid:1721420
|
Goebl MG |
The peptidyl-prolyl isomerase, FK506-binding protein, is most likely the 12 kd endogenous inhibitor 2 of protein kinase C. |
1991 |
Cell |
pmid:1706222
|
de Paulis A et al. |
FK-506, a potent novel inhibitor of the release of proinflammatory mediators from human Fc epsilon RI+ cells. |
1991 |
J. Immunol. |
pmid:1706398
|
Abu-Elmagd K et al. |
Efficacy of FK 506 in the treatment of recalcitrant pyoderma gangrenosum. |
1991 |
Transplant. Proc. |
pmid:1721451
|
Thomson AW et al. |
Influence of FK 506 on T lymphocytes, Langerhans' cells and the expression of cytokine receptors and adhesion molecules in psoriatic skin lesions: a preliminary study. |
1991 |
Transplant. Proc. |
pmid:1721452
|
Hultsch T et al. |
Immunophilin ligands demonstrate common features of signal transduction leading to exocytosis or transcription. |
1991 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:1712484
|
Miyahara H et al. |
Comparative studies of the effects of FK506 and cyclosporin A on passively transferred collagen-induced arthritis in rats. |
1991 |
Clin. Immunol. Immunopathol. |
pmid:1712688
|
Fung JJ et al. |
Conversion of liver allograft recipients from cyclosporine to FK 506-based immunosuppression: benefits and pitfalls. |
1991 |
Transplant. Proc. |
pmid:1703682
|
Marquis-Omer D et al. |
Stabilization of the FK506 binding protein by ligand binding. |
1991 |
Biochem. Biophys. Res. Commun. |
pmid:1716886
|
Wu J et al. |
Comparative immunoregulatory effects of rapamycin, FK 506 and cyclosporine on mitogen-induced cytokine production and lymphoproliferation. |
1991 |
Transplant. Proc. |
pmid:1703683
|
Sakai K et al. |
[The effect of a new immunosuppressive agent, FK-506, on xenogeneic neural transplantation in rodents--comparison with cyclosporin A]. |
1991 |
No To Shinkei |
pmid:1716937
|
Yoshimura R et al. |
A comparative study between cyclosporine and FK 506 effects on renal microsomal P-450. |
1991 |
Transplant. Proc. |
pmid:1703686
|
McWhinnie DL and Morris PJ |
Combination drug therapies for immunosuppression in transplantation. |
1991 |
Ann. Acad. Med. Singap. |
pmid:1724724
|
Pourtier-Manzanedo A et al. |
FK-506 (fujimycin) reverses the multidrug resistance of tumor cells in vitro. |
1991 |
Anticancer Drugs |
pmid:1724925
|
Jordan ML et al. |
Initial studies with FK506 in renal transplantation. |
1991 Sep-Oct |
Cleve Clin J Med |
pmid:1718631
|
Kuo CJ et al. |
Rapamycin selectively inhibits interleukin-2 activation of p70 S6 kinase. |
1992 |
Nature |
pmid:1614535
|
Takaya S et al. |
The adverse impact on liver transplantation of using positive cytotoxic crossmatch donors. |
1992 |
Transplantation |
pmid:1371195
|
Francavilla A et al. |
Inhibition of liver, kidney, and intestine regeneration by rapamycin. |
1992 |
Transplantation |
pmid:1371198
|
Matsukawa W et al. |
Effects of a new immunosuppressive agent, FK506, in rats with active Heymann nephritis. |
1992 |
J. Lab. Clin. Med. |
pmid:1371298
|
Sampson BA and Gotschlich EC |
Neisseria meningitidis encodes an FK506-inhibitable rotamase. |
1992 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:1371354
|
Andersson J et al. |
Effects of FK506 and cyclosporin A on cytokine production studied in vitro at a single-cell level. |
1992 |
Immunology |
pmid:1371491
|
Strasser S et al. |
Effect of FK506 on insulin secretion in normal dogs. |
1992 |
Metab. Clin. Exp. |
pmid:1371575
|
Andersson J et al. |
FK 506 and cyclosporine inhibit antigen- or mitogen-induced monokine and lymphokine production in vitro. |
1992 |
Transplant. Proc. |
pmid:1371621
|
Matsuura T et al. |
Blockade of interleukin-2 production from cloned T cells by cyclosporine and FK 506 assessed by proliferation assays in vitro. |
1992 |
Transplant. Proc. |
pmid:1371623
|
Okamura N et al. |
Enhanced liver regeneration by FK 506 can be blocked by interleukin-1 alpha and interleukin-2. |
1992 |
Transplant. Proc. |
pmid:1371624
|
Metcalfe S et al. |
FK506 and rapamycin: differential sensitivity of human, baboon, cynomolgus monkey, dog and pig lymphocytes. |
1992 |
Transpl. Int. |
pmid:14621863
|
|
Japanese study of kidney transplantation: 1. Results of early phase II study. |
1992 |
Transpl. Int. |
pmid:14621866
|
|
Japanese study of FK 506 on kidney transplantation: 2. Follow-up study of FK 506-treated patients. |
1992 |
Transpl. Int. |
pmid:14621874
|
Walpoth B et al. |
Prevention of cardiac allograft rejection by FK506 and rapamycin: assessment by histology and nuclear magnetic resonance. |
1992 |
Transpl. Int. |
pmid:14621877
|
Asako H et al. |
Reduction of leukocyte adherence and emigration by cyclosporine and L683,590 (FK506) in postcapillary venules. |
1992 |
Transplantation |
pmid:1384191
|
Kawano K et al. |
FK 506 ameliorates normothermic liver ischemia in rats by suppressing production of tumor necrosis factor. |
1992 |
Transpl. Int. |
pmid:14621904
|
Fruman DA et al. |
Calcineurin phosphatase activity in T lymphocytes is inhibited by FK 506 and cyclosporin A. |
1992 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:1373887
|
Lake JR et al. |
Maintenance immunosuppression after liver transplantation. |
1992 |
Semin. Liver Dis. |
pmid:1373916
|
Taormina D et al. |
Stability and sorption of FK 506 in 5% dextrose injection and 0.9% sodium chloride injection in glass, polyvinyl chloride, and polyolefin containers. |
1992 |
Am J Hosp Pharm |
pmid:1373936
|
Ochiai T |
[Advances in the fundamentals and therapeutic use of immunosuppressive agents]. |
1992 |
Arerugi |
pmid:1374229
|
Yamada K et al. |
New morphological changes induced by FK506 in a short period in the rat kidney and the effect of superoxide dismutase and OKY-046 on THEM: the relationship of FK506 nephrotoxicity to lipid peroxidation and change in production of thromboxane A2 in the kidney. |
1992 |
Transpl. Int. |
pmid:14621878
|
Hung DT and Schreiber SL |
cDNA cloning of a human 25 kDa FK506 and rapamycin binding protein. |
1992 |
Biochem. Biophys. Res. Commun. |
pmid:1374240
|
Jayaraman T et al. |
FK506 binding protein associated with the calcium release channel (ryanodine receptor). |
1992 |
J. Biol. Chem. |
pmid:1374404
|
Höllsberg P et al. |
Characterization of HTLV-I in vivo infected T cell clones. IL-2-independent growth of nontransformed T cells. |
1992 |
J. Immunol. |
pmid:1374452
|
Schreiber SL and Crabtree GR |
The mechanism of action of cyclosporin A and FK506. |
1992 |
Immunol. Today |
pmid:1374612
|
Demetris AJ et al. |
Conversion of liver allograft recipients from cyclosporine to FK506 immunosuppressive therapy--a clinicopathologic study of 96 patients. |
1992 |
Transplantation |
pmid:1374944
|
Ricordi C et al. |
Effect of FK 506 on human pancreatic islets following renal subcapsular transplantation in diabetic nude mice. |
1992 |
Transplant. Proc. |
pmid:1376512
|
Hisanaga M et al. |
Successful combination therapy with FK 506 and 15-deoxyspergualin in pancreatic islet xenografting. |
1992 |
Transplant. Proc. |
pmid:1376513
|
Ogasa N et al. |
Successful transplantation of newborn rat intestine as a free graft. |
1992 |
Transplant. Proc. |
pmid:1376514
|
Graeb C et al. |
Cytoimmunologic monitoring of small bowel allograft recipients. |
1992 |
Transplant. Proc. |
pmid:1376515
|
Date K et al. |
Effect of FK 506 on graft survival in rat small intestinal allografts. |
1992 |
Transplant. Proc. |
pmid:1376516
|
Hatazawa C et al. |
Effect of FK 506 on bowel transplantation in rats. |
1992 |
Transplant. Proc. |
pmid:1376517
|
Jain A et al. |
Intravenous, oral pharmacokinetics, and oral dosing of FK 506 in small bowel transplant patients. |
1992 |
Transplant. Proc. |
pmid:1376518
|
Masutani H et al. |
Suppression of the histologic changes of GVHD by FK 506 in rat small bowel transplantation. |
1992 |
Transplant. Proc. |
pmid:1376519
|
Santiago SF et al. |
Effect of short-term immunosuppressive therapy with FK 506 or CyA on the donor in small intestine allotransplantation in rats. |
1992 |
Transplant. Proc. |
pmid:1376520
|
Foor F et al. |
Calcineurin mediates inhibition by FK506 and cyclosporin of recovery from alpha-factor arrest in yeast. |
1992 |
Nature |
pmid:1281518
|
Goldfeld AE et al. |
Transcription of the tumor necrosis factor alpha gene is rapidly induced by anti-immunoglobulin and blocked by cyclosporin A and FK506 in human B cells. |
1992 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:1281550
|
Morikawa K et al. |
The distinct effects of FK506 on the activation, proliferation, and differentiation of human B lymphocytes. |
1992 |
Transplantation |
pmid:1281561
|
Moutabarrik A et al. |
FK506-induced kidney tubular cell injury. |
1992 |
Transplantation |
pmid:1281562
|
Yagihashi A et al. |
HLA matching effect in liver transplantation. |
1992 |
Transplant. Proc. |
pmid:1281569
|
Kobayashi M et al. |
Posttransplant donor-specific T-lymphocytotoxic antibody in liver transplant patients with a positive crossmatch. |
1992 |
Transplant. Proc. |
pmid:1281570
|
Lemster B et al. |
Cytokine gene expression in murine lymphocytes activated in the presence of FK 506, bredinin, mycophenolic acid, or brequinar sodium. |
1992 |
Transplant. Proc. |
pmid:1281576
|
Tze WJ et al. |
FK 506: an effective immunosuppressant for islet xenotransplantation. |
1992 |
Transplant. Proc. |
pmid:1281577
|
Kamei T et al. |
Established intraportal islet allograft is rejected despite the acceptance of donor-specific second cardiac allograft. |
1992 |
Transplant. Proc. |
pmid:1281579
|
Kenmochi T et al. |
[The effect of FK506 on segmental pancreas allograft in mongrel dogs]. |
1992 |
Nihon Geka Gakkai Zasshi |
pmid:1378526
|
Mouzaki A et al. |
Cyclosporin A and FK506 prevent the derepression of the IL-2 gene in mitogen-induced primary T lymphocytes. |
1992 |
Cytokine |
pmid:1378764
|
Ramamoorthy S et al. |
Selective impairment of taurine transport by cyclosporin A in a human placental cell line. |
1992 |
Pediatr. Res. |
pmid:1378960
|
Armitage JM et al. |
Clinical trial of FK 506 immunosuppression in adult cardiac transplantation. |
1992 |
Ann. Thorac. Surg. |
pmid:1379032
|
Thomson AW |
The spectrum of action of new immunosuppressive drugs. |
1992 |
Clin. Exp. Immunol. |
pmid:1379130
|
Fischer G et al. |
Mip protein of Legionella pneumophila exhibits peptidyl-prolyl-cis/trans isomerase (PPlase) activity. |
1992 |
Mol. Microbiol. |
pmid:1379319
|
Rondeau E |
[Mechanism of action of the new immunosuppressants: cyclosporin A, FK 506 and rapamycin]. |
1992 |
Nephrologie |
pmid:1379348
|
Schreiber SL |
Immunophilin-sensitive protein phosphatase action in cell signaling pathways. |
1992 |
Cell |
pmid:1379518
|
Aldape RA et al. |
Charged surface residues of FKBP12 participate in formation of the FKBP12-FK506-calcineurin complex. |
1992 |
J. Biol. Chem. |
pmid:1379588
|
Langrehr JM et al. |
Nitric oxide production in host-versus-graft and graft-versus-host reactions in the rat. |
1992 |
J. Clin. Invest. |
pmid:1379617
|
Price DJ et al. |
Rapamycin-induced inhibition of the 70-kilodalton S6 protein kinase. |
1992 |
Science |
pmid:1380182
|
Granelli-Piperno A |
SRC-related proto-oncogenes and transcription factors in primary human T cells: modulation by cyclosporin A and FK506. |
1992 |
J. Autoimmun. |
pmid:1380242
|
Reem GH |
Molecular mode of action of cyclosporin and FK506 in human thymocytes. |
1992 |
J. Autoimmun. |
pmid:1380243
|
Bach JF |
Immunointervention in autoimmune diseases from cellular selectivity to autoantigen specificity. |
1992 |
J. Autoimmun. |
pmid:1380245
|
Baumann G et al. |
Molecular mechanisms of immunosuppression. |
1992 |
J. Autoimmun. |
pmid:1380246
|
Walpoth B et al. |
Assessment of new immunosuppressive drugs in a rat cardiac allograft heterotopic model. |
1992 |
Eur Surg Res |
pmid:1380460
|
Petros AM et al. |
Conformation of two non-immunosuppressive FK506 analogs when bound to FKBP by isotope-filtered NMR. |
1992 |
FEBS Lett. |
pmid:1380470
|
Van Thiel DH et al. |
FK 506 reduces the injury experienced following renal ischemia and reperfusion. |
1992 |
Ren Fail |
pmid:1380720
|
Bolton C |
The efficacy of cyclosporin A, FK-506 and prednisolone to modify the adoptive transfer of experimental allergic encephalomyelitis (EAE). |
1992 |
Agents Actions |
pmid:1380765
|
Langrehr JM et al. |
Evidence that indefinite survival of small bowel allografts achieved by a brief course of cyclosporine or FK506 is not due to systemic hyporesponsiveness. |
1992 |
Transplantation |
pmid:1384185
|
McCarthy SA et al. |
The effects of immunosuppressive drugs on the regulation of activation-induced apoptotic cell death in thymocytes. |
1992 |
Transplantation |
pmid:1384186
|
Dhar DK et al. |
The salutary effect of FK506 in ischemia-reperfusion injury of the canine liver. |
1992 |
Transplantation |
pmid:1384188
|
Ericzon BG et al. |
FK506-induced impairment of glucose metabolism in the primate--studies in pancreatic transplant recipients and in nontransplanted animals. |
1992 |
Transplantation |
pmid:1384189
|
Meiser BM et al. |
Continuous infusion of angiopeptin significantly reduces accelerated graft vessel disease induced by FK 506 in a rat heart allograft model. |
1992 |
Transplant. Proc. |
pmid:1384201
|
Wakabayashi H et al. |
Effect of FK 506 and cyclosporine A on hepatic energy status in the rat after warm ischemia, as monitored by 31P nuclear magnetic resonance spectroscopy in vivo. |
1992 |
Transplant. Proc. |
pmid:1384205
|
Griffin AD et al. |
FK 506 in canine renal transplantation. |
1992 |
Transplant. Proc. |
pmid:1384209
|
Griffiths RJ et al. |
Characterisation of passively transferred antigen arthritis induced by methylated bovine serum albumin in the rat: effect of FK 506 on arthritis development. |
1992 |
Agents Actions |
pmid:1384284
|
Todo S et al. |
Intestinal transplantation in composite visceral grafts or alone. |
1992 |
Ann. Surg. |
pmid:1384443
|